The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs Based on TGF-β1 Market Research Report 2025
Synopsis
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
The global Drugs Based on TGF-β1 market was valued at US$ 1311 million in 2023 and is anticipated to reach US$ 2093.7 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs Based on TGF-β1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Based on TGF-β1.
Report Scope
The Drugs Based on TGF-β1 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs Based on TGF-β1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs Based on TGF-β1 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Shionogi Ltd
Segment by Type
Pirfenidone
Galunisertib
Others
Segment by Application
IPF
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs Based on TGF-β1 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
The global Drugs Based on TGF-β1 market was valued at US$ 1311 million in 2023 and is anticipated to reach US$ 2093.7 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs Based on TGF-β1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Based on TGF-β1.
Report Scope
The Drugs Based on TGF-β1 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs Based on TGF-β1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs Based on TGF-β1 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Shionogi Ltd
Segment by Type
Pirfenidone
Galunisertib
Others
Segment by Application
IPF
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs Based on TGF-β1 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs Based on TGF-β1 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drugs Based on TGF-β1 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs Based on TGF-β1 Market Perspective (2019-2030)
2.2 Drugs Based on TGF-β1 Growth Trends by Region
2.2.1 Global Drugs Based on TGF-β1 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs Based on TGF-β1 Historic Market Size by Region (2019-2024)
2.2.3 Drugs Based on TGF-β1 Forecasted Market Size by Region (2025-2030)
2.3 Drugs Based on TGF-β1 Market Dynamics
2.3.1 Drugs Based on TGF-β1 Industry Trends
2.3.2 Drugs Based on TGF-β1 Market Drivers
2.3.3 Drugs Based on TGF-β1 Market Challenges
2.3.4 Drugs Based on TGF-β1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs Based on TGF-β1 Players by Revenue
3.1.1 Global Top Drugs Based on TGF-β1 Players by Revenue (2019-2024)
3.1.2 Global Drugs Based on TGF-β1 Revenue Market Share by Players (2019-2024)
3.2 Global Drugs Based on TGF-β1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs Based on TGF-β1 Revenue
3.4 Global Drugs Based on TGF-β1 Market Concentration Ratio
3.4.1 Global Drugs Based on TGF-β1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on TGF-β1 Revenue in 2023
3.5 Drugs Based on TGF-β1 Key Players Head office and Area Served
3.6 Key Players Drugs Based on TGF-β1 Product Solution and Service
3.7 Date of Enter into Drugs Based on TGF-β1 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs Based on TGF-β1 Breakdown Data by Type
4.1 Global Drugs Based on TGF-β1 Historic Market Size by Type (2019-2024)
4.2 Global Drugs Based on TGF-β1 Forecasted Market Size by Type (2025-2030)
5 Drugs Based on TGF-β1 Breakdown Data by Application
5.1 Global Drugs Based on TGF-β1 Historic Market Size by Application (2019-2024)
5.2 Global Drugs Based on TGF-β1 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drugs Based on TGF-β1 Market Size (2019-2030)
6.2 North America Drugs Based on TGF-β1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drugs Based on TGF-β1 Market Size by Country (2019-2024)
6.4 North America Drugs Based on TGF-β1 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs Based on TGF-β1 Market Size (2019-2030)
7.2 Europe Drugs Based on TGF-β1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drugs Based on TGF-β1 Market Size by Country (2019-2024)
7.4 Europe Drugs Based on TGF-β1 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs Based on TGF-β1 Market Size (2019-2030)
8.2 Asia-Pacific Drugs Based on TGF-β1 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2019-2024)
8.4 Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs Based on TGF-β1 Market Size (2019-2030)
9.2 Latin America Drugs Based on TGF-β1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drugs Based on TGF-β1 Market Size by Country (2019-2024)
9.4 Latin America Drugs Based on TGF-β1 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs Based on TGF-β1 Market Size (2019-2030)
10.2 Middle East & Africa Drugs Based on TGF-β1 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2019-2024)
10.4 Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Drugs Based on TGF-β1 Introduction
11.1.4 Roche Revenue in Drugs Based on TGF-β1 Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Shionogi Ltd
11.2.1 Shionogi Ltd Company Detail
11.2.2 Shionogi Ltd Business Overview
11.2.3 Shionogi Ltd Drugs Based on TGF-β1 Introduction
11.2.4 Shionogi Ltd Revenue in Drugs Based on TGF-β1 Business (2019-2024)
11.2.5 Shionogi Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Drugs Based on TGF-β1 Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Pirfenidone
Table 3. Key Players of Galunisertib
Table 4. Key Players of Others
Table 5. Global Drugs Based on TGF-β1 Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Drugs Based on TGF-β1 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drugs Based on TGF-β1 Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Drugs Based on TGF-β1 Market Share by Region (2019-2024)
Table 9. Global Drugs Based on TGF-β1 Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Drugs Based on TGF-β1 Market Share by Region (2025-2030)
Table 11. Drugs Based on TGF-β1 Market Trends
Table 12. Drugs Based on TGF-β1 Market Drivers
Table 13. Drugs Based on TGF-β1 Market Challenges
Table 14. Drugs Based on TGF-β1 Market Restraints
Table 15. Global Drugs Based on TGF-β1 Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Drugs Based on TGF-β1 Market Share by Players (2019-2024)
Table 17. Global Top Drugs Based on TGF-β1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on TGF-β1 as of 2023)
Table 18. Ranking of Global Top Drugs Based on TGF-β1 Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Drugs Based on TGF-β1 Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs Based on TGF-β1 Product Solution and Service
Table 22. Date of Enter into Drugs Based on TGF-β1 Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs Based on TGF-β1 Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2019-2024)
Table 26. Global Drugs Based on TGF-β1 Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2025-2030)
Table 28. Global Drugs Based on TGF-β1 Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2019-2024)
Table 30. Global Drugs Based on TGF-β1 Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2025-2030)
Table 32. North America Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Drugs Based on TGF-β1 Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Drugs Based on TGF-β1 Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Drugs Based on TGF-β1 Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Drugs Based on TGF-β1 Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Drugs Based on TGF-β1 Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Drugs Based on TGF-β1 Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Drugs Based on TGF-β1 Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Drugs Based on TGF-β1 Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Drugs Based on TGF-β1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2025-2030) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Drugs Based on TGF-β1 Product
Table 50. Roche Revenue in Drugs Based on TGF-β1 Business (2019-2024) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Shionogi Ltd Company Detail
Table 53. Shionogi Ltd Business Overview
Table 54. Shionogi Ltd Drugs Based on TGF-β1 Product
Table 55. Shionogi Ltd Revenue in Drugs Based on TGF-β1 Business (2019-2024) & (US$ Million)
Table 56. Shionogi Ltd Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs Based on TGF-β1 Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drugs Based on TGF-β1 Market Share by Type: 2023 VS 2030
Figure 3. Pirfenidone Features
Figure 4. Galunisertib Features
Figure 5. Others Features
Figure 6. Global Drugs Based on TGF-β1 Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Drugs Based on TGF-β1 Market Share by Application: 2023 VS 2030
Figure 8. IPF Case Studies
Figure 9. Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Drugs Based on TGF-β1 Report Years Considered
Figure 12. Global Drugs Based on TGF-β1 Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Drugs Based on TGF-β1 Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drugs Based on TGF-β1 Market Share by Region: 2023 VS 2030
Figure 15. Global Drugs Based on TGF-β1 Market Share by Players in 2023
Figure 16. Global Top Drugs Based on TGF-β1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on TGF-β1 as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Drugs Based on TGF-β1 Revenue in 2023
Figure 18. North America Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Drugs Based on TGF-β1 Market Share by Country (2019-2030)
Figure 20. United States Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Drugs Based on TGF-β1 Market Share by Country (2019-2030)
Figure 24. Germany Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Drugs Based on TGF-β1 Market Share by Region (2019-2030)
Figure 32. China Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Drugs Based on TGF-β1 Market Share by Country (2019-2030)
Figure 40. Mexico Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Drugs Based on TGF-β1 Market Share by Country (2019-2030)
Figure 44. Turkey Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Drugs Based on TGF-β1 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Drugs Based on TGF-β1 Business (2019-2024)
Figure 47. Shionogi Ltd Revenue Growth Rate in Drugs Based on TGF-β1 Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
